PRKCG and memory: Recently, (Huang et al., 2012) reported that reduction of the PKCγ-ERK (extracellular signal-regulated protein kinase) signaling pathway activation was involved in hippocampal neurodegeneration and persistent learning and memory impairments induced by ketamine, a NMDA receptor antagonist.